Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

132 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemoradiotherapy versus radiotherapy alone in the management of early-stage anal squamous cell carcinoma: A comparative analysis of the French cohort FFCD-ANABASE.
Buchalet C, Lemanski C, Pommier P, Le Malicot K, Bonichon-Lamichhane N, Evesque L, Diaz O, Ronchin P, Quero L, Campo ERD, Tougeron D, Salas S, Bengrine-Lefevre L, Lepage C, Vendrely V. Buchalet C, et al. Among authors: lemanski c. Dig Liver Dis. 2024 Jul 12:S1590-8658(24)00832-6. doi: 10.1016/j.dld.2024.06.022. Online ahead of print. Dig Liver Dis. 2024. PMID: 39003165
Management of non-metastatic anal cancer in the elderly: ancillary study of the French multicenter prospective cohort FFCD-ANABASE.
Gouriou C, Lemanski C, Pommier P, Le Malicot K, Saint A, Rivin Del Campo E, Evin C, Quero L, Regnault P, Baba-Hamed N, Ronchin P, Crehange G, Tougeron D, Menager-Tabourel E, Diaz O, Hummelsberger M, de la Rocherfordiere A, Drouet F, Vendrely V, Lièvre A. Gouriou C, et al. Among authors: lemanski c. Br J Cancer. 2024 Mar;130(5):769-776. doi: 10.1038/s41416-023-02564-9. Br J Cancer. 2024. PMID: 38184691
GRECCAR 14 - a multicentric, randomized, phase II-III study evaluating the tailored management of locally advanced rectal carcinoma after a favourable response to induction chemotherapy: Study protocol.
Rouanet P, Castan F, Mazard T, Lemanski C, Nougaret S, Deshayes E, Chalbos P, Gourgou S, Taoum C; GRECCAR, PRODIGE study group. Rouanet P, et al. Among authors: lemanski c. Colorectal Dis. 2023 Oct;25(10):2078-2086. doi: 10.1111/codi.16740. Epub 2023 Sep 11. Colorectal Dis. 2023. PMID: 37697712
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
Niyoteka S, Seban RD, Rouhi R, Scarsbrook A, Genestie C, Classe M, Carré A, Sun R, La Greca Saint-Esteven A, Chargari C, McKenna J, McDermott G, Malinen E, Tanadini-Lang S, Guckenberger M, Guren MG, Lemanski C, Deutsch E, Robert C. Niyoteka S, et al. Among authors: lemanski c. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4010-4023. doi: 10.1007/s00259-023-06320-2. Epub 2023 Aug 26. Eur J Nucl Med Mol Imaging. 2023. PMID: 37632562
[Events and errors in radiation oncology: Conciliating perspectives to support care].
Haaser T, Constantinides Y, Osman D, Lahmi L, Durdux C, Bourbonne V, Cheval V, de Crevoisier R, Dejean C, Ducteil A, Escande A, Gesbert C, Ghannam Y, Lemanski C, Thureau S, Lagrange JL, Huguet F; Commission éthique de la Société française de radiothérapie oncologique (SFRO). Haaser T, et al. Among authors: lemanski c. Cancer Radiother. 2024 Nov;28(6-7):527-533. doi: 10.1016/j.canrad.2024.07.017. Epub 2024 Oct 5. Cancer Radiother. 2024. PMID: 39368919 French.
Efficacy and Toxicity of (Chemo)Radiation Therapy in HIV+ Patients with Squamous Cell Anal Cancer, a Subgroup Analysis of the National Multicenter Cohort FFCD-ANABASE.
Evin C, Quéro L, Le Malicot K, Blanchet-Deverly S, Evesque L, Buchalet C, Lemanski C, Hamed NB, Rivin Del Campo E, Bauwens L, Pommier P, Lièvre A, Gouriou C, Tougeron D, Macé V, Sergent G, Diaz O, Zucman D, Mornex F, Locher C, De la Rochefordière A, Vendrely V, Huguet F. Evin C, et al. Among authors: lemanski c. Int J Radiat Oncol Biol Phys. 2024 Nov 1;120(3):708-719. doi: 10.1016/j.ijrobp.2024.04.067. Epub 2024 Jun 21. Int J Radiat Oncol Biol Phys. 2024. PMID: 38912999
Panitumumab in combination with chemoradiotherapy for the treatment of locally-advanced anal canal carcinoma: Results of the FFCD 0904 phase II trial.
Vendrely V, Ronchin P, Minsat M, Le Malicot K, Lemanski C, Mirabel X, Etienne PL, Lièvre A, Darut-Jouve A, de la Fouchardière C, Giraud N, Breysacher G, Argo-Leignel D, Thimonnier E, Magné N, Abdelghani MB, Lepage C, Aparicio T; for FFCD investigators/Collaborators. Vendrely V, et al. Among authors: lemanski c. Radiother Oncol. 2023 Sep;186:109742. doi: 10.1016/j.radonc.2023.109742. Epub 2023 Jun 12. Radiother Oncol. 2023. PMID: 37315583 Free article. Clinical Trial.
Treatment, outcome, and prognostic factors in non-metastatic anal cancer: The French nationwide cohort study FFCD-ANABASE.
Vendrely V, Lemanski C, Pommier P, LE Malicot K, Saint A, Rivin Del Campo E, Regnault P, Baba-Hamed N, Ronchin P, Crehange G, Tougeron D, Menager-Tabourel E, Diaz O, Hummelsberger M, Minsat M, Drouet F, Larrouy A, Peiffert D, Lievre A, Zasadny X, Hautefeuille V, Mornex F, Lepage C, Quero L; for FFCD investigators/collaborators. Vendrely V, et al. Among authors: lemanski c. Radiother Oncol. 2023 Jun;183:109542. doi: 10.1016/j.radonc.2023.109542. Epub 2023 Feb 21. Radiother Oncol. 2023. PMID: 36813175 Free article.
132 results